Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards

Dialectic Therapeutics raises more than $6M

By Sean Whooley | February 12, 2021

Dialectic Therapeutics issued an SEC Form D to confirm the sale of nearly $6.4 million in debt, options, warrants and/or other rights to purchase securities.

According to the filing, the Dallas-based cancer treatment technology developer made the first sale in its offering of $6.35 million on Dec. 15, 2020. The $6.35 million already sold is the total amount being offered.

In total, 27 investors contributed to the amended offering, which is not being made in connection with a merger, acquisition or another form of business combination transaction.

The minimum investment accepted by Dialectic Therapeutics was $50,000. The company confirmed that $100,000 of the proceeds collected in the offering is earmarked for payments to a number of executive officers, directors or promoters. No other intended use of proceeds was listed.

Dialectic Therapeutics is a pre-clinical biotechnology company developing anti-cancer drugs with limited toxicities and complications for treating patients with few to no other options, according to the company’s website.

Tell Us What You Think! Cancel reply

You must be logged in to post a comment.

Related Articles Read More >

Endevica
Investigational drug promises to reverse wasting syndrome in cancer patients
Nodular melanoma
BioNTech and Moderna set their sights on treating cancer
4D Path
4D Path and University of Leeds extend partnership to validate oncology platform
Q&A: Why IMV’s DPX-Survivac shows promise in treating ovarian cancer

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Drug Discovery news in a minute?

We Deliver!
Drug Discovery & Development Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Drug Discovery and Development
  • Enews Signup
  • Contact Us
  • R&D World
  • Pharmaceutical Processing
  • Drug Delivery Business News

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery

  • Home Drug Discovery and Development
  • Drug Discovery
  • Genomics/Proteomics
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Orphan Drugs
  • R&D 100 Awards